ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings Inc (RVPH)

1.89
0.05
(2.72%)
Cerrado 03 Febrero 3:00PM
1.8016
-0.0884
(-4.68%)
Fuera de horario: 6:59PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
1.8016
Postura de Compra
1.82
Postura de Venta
1.88
Volume Operado de la Acción
944,836
1.78 Rango del Día 1.89
0.60 Rango de 52 semanas 4.83
Capitalización de Mercado [m]
Precio Anterior
1.84
Precio de Apertura
1.85
Última hora de negociación
Volumen financiero
US$ 1,732,417
Precio Promedio Ponderado
1.8336
Volumen promedio (3 m)
3,056,860
Acciones en circulación
33,441,199
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-7.45
Beneficio por acción (BPA)
-1.17
turnover
-
Beneficio neto
-39.26M

Acerca de Reviva Pharmaceuticals Holdings Inc

Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the dev... Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis. Mostrar más

Sector
Blank Checks
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
2018
Reviva Pharmaceuticals Holdings Inc is listed in the Blank Checks sector of the NASDAQ with ticker RVPH. The last closing price for Reviva Pharmaceuticals was US$1.84. Over the last year, Reviva Pharmaceuticals shares have traded in a share price range of US$ 0.60 to US$ 4.83.

Reviva Pharmaceuticals currently has 33,441,199 shares in issue. The market capitalisation of Reviva Pharmaceuticals is US$61.53 million. Reviva Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.45.

RVPH Últimas noticias

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces Business Updates NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0484-2.616216216221.851.97881.6812333051.82050257CS
4-0.1884-9.467336683421.992.171.5624263711.87624355CS
120.861691.65957446810.944.280.88230568601.87899991CS
260.691662.30630630631.114.280.615983301.75370376CS
52-2.2184-55.1840796024.024.830.69516731.87881671CS
1560.15169.187878787881.659.24990.536529392.78857787CS
260-7.6584-80.9556025379.469.610.536173033.67812257CS

RVPH - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Reviva Pharmaceuticals?
El precio actual de las acciones de Reviva Pharmaceuticals es US$ 1.8016
¿Cuántas acciones de Reviva Pharmaceuticals están en circulación?
Reviva Pharmaceuticals tiene 33,441,199 acciones en circulación
¿Cuál es la capitalización de mercado de Reviva Pharmaceuticals?
La capitalización de mercado de Reviva Pharmaceuticals es USD 61.53M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Reviva Pharmaceuticals?
Reviva Pharmaceuticals ha negociado en un rango de US$ 0.60 a US$ 4.83 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Reviva Pharmaceuticals?
El ratio precio/beneficio de Reviva Pharmaceuticals es -7.45
¿Cuál es la moneda de reporte de Reviva Pharmaceuticals?
Reviva Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Reviva Pharmaceuticals?
El último beneficio anual de Reviva Pharmaceuticals es USD -39.26M
¿Cuál es la dirección registrada de Reviva Pharmaceuticals?
La dirección registrada de Reviva Pharmaceuticals es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Reviva Pharmaceuticals?
La dirección del sitio web de Reviva Pharmaceuticals es revivapharma.com
¿En qué sector industrial opera Reviva Pharmaceuticals?
Reviva Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
872.46k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.5M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
341.8M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
237.15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.44M

RVPH Discussion

Ver más
Eagle1 Eagle1 3 días hace
RVPH Nice chart here glenn. Thanks looking forward to a nice move here soon.

RVPH.....................................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 semanas hace
RVPH.....................................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
Eagle1 Eagle1 1 mes hace
RVPH 1.8797 0.0797 (4.43%) 12-30-24
👍️0
glenn1919 glenn1919 1 mes hace
RVPH...........................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
Eagle1 Eagle1 1 mes hace
RVPH $1.63 0.29 (+21.64%) Liking this one, can't believe you didn't alert me before...

shame on you, LOL jk buddy, lets see this to $3.00++ soon looks very solid.
👍️0
govprs govprs 1 mes hace
Great place to add.  Gltu 
👍️0
Eagle1 Eagle1 1 mes hace
Added here!
👍 1
glenn1919 glenn1919 1 mes hace
RVPH..................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
McMagyar McMagyar 1 mes hace
Pulling defeat from absolute victory.
Absolute Trainwreck of a management team..
Sad to watch..
If you had a competent ceo .. this would have been a billion dollar market cap..
No One has confidence in the ceo other than to bank his paycheck.. 
so many people could have been helped with this drug .. by the time they get approval the patent will be gone.. maybe they will crystallize the formula and we can start all over again..
Just tough to watch.. usually the system screws these small biopharms, but Reviva over decades seems to have a talent( not unique) of finding ways do it to themselves
👍️0
glenn1919 glenn1919 2 meses hace
RVPH........................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 meses hace
RVPH.............................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 meses hace
RVPH...........................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 meses hace
RVPH...............................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
Paullee Paullee 2 meses hace
crazy going on today
👍️0
govprs govprs 2 meses hace
Might be imminent big vol today
👍️0
stockweiser stockweiser 2 meses hace
OLE data in December. 
👍️0
Termite7 Termite7 2 meses hace
Any news before year end? .......Thanks!!!!
👍️0
glenn1919 glenn1919 3 meses hace
RVPH.......................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
Termite7 Termite7 4 meses hace
ETA on approval? .......Thanks!!!
👍️0
Imokhopeur Imokhopeur 5 meses hace
No doubt Termite
👍️0
Termite7 Termite7 5 meses hace
This could get to $8-or-$12 depending upon drug-approval.......


......and their pipeline is HUGE!!!!
👍️0
glenn1919 glenn1919 5 meses hace
RVPH.................................https://stockcharts.com/h-sc/ui?s=RVPH&p=W&b=5&g=0&id=p86431144783
👍️0
Imokhopeur Imokhopeur 5 meses hace
It will soon make up its mind to pass 1.00 and quickly move up!!!
👍️0
Triple nickle Triple nickle 5 meses hace
Weeee
👍️0
Imokhopeur Imokhopeur 6 meses hace
Buy
👍️0
Monksdream Monksdream 6 meses hace
RVPH new 52=low
👍️0
Monksdream Monksdream 6 meses hace
RVPH new 52 week low
👍️0
Monroe1 Monroe1 7 meses hace
Thanks!
👍️0
OPennyS OPennyS 7 meses hace
Because we have a long wait.

This data is crucial for their planned New Drug Application (NDA) submission to the FDA, expected in the fourth quarter of 2025.
👍️ 1
Paullee Paullee 7 meses hace
https://synapse.patsnap.com/article/reviva-updates-enrollment-for-brilaroxazine-schizophrenia-study
👍️ 1
Monroe1 Monroe1 7 meses hace
Why is this continuing to tank? Trial data not good?
👍️0
McMagyar McMagyar 10 meses hace
Well it’s below 4 not 3..
And I am praying they just sell but..
Arrogance is strong..
Also Nutriband is killing it..
Also anavex just announce the start of their schizophrenia trial..

Sell the co doc.. what lease can I say
👍️0
Monksdream Monksdream 10 meses hace
RVPH under $3
👍️0
McMagyar McMagyar 1 año hace
We’re just gonna wake up to a $200 sold co..
👍️0
govprs govprs 1 año hace
Im back in now for the next flip opportunity
👍️0
2H2 2H2 1 año hace
I closed out my shares end of day. Way outside daily bb, renter on pullback
👍️0
govprs govprs 1 año hace
I would fade this. I did to be honest got a nice profit today. I believe a buyout is possible here but they need to make progress p3 trial. I’m looking to re-enter 380 -405 range. Glta
👍️0
2H2 2H2 1 año hace
KRTX bought by BMY
👍️0
McMagyar McMagyar 1 año hace
I thought this was anavex!!

Haha

Revival would make sense
They have poorly managed the finances and development of this great drug for decades
Let someone else bring it to market
👍️0
McMagyar McMagyar 1 año hace
That would be a disaster for humanity
Poison pill to discourage such activity is in place
There will be no buyout
There will be no marketing partnerships

We are going straight to govts to lower their healthcare costs
👍️0
2H2 2H2 1 año hace
Potential buyout here soon imo
👍️0
McMagyar McMagyar 1 año hace
Another drug which Blarcamesine could act as empowering agent
👍️0
McMagyar McMagyar 1 año hace
Because it’s a lifelong drug..
It treats symptoms safely.. but
unfortunately deoant cure the imbalance
so .. once someone is on.. they will probably never stop ..

Phase 4 confirmatory / safety would make more sense ..after nda filed and drug aold
👍️0
McMagyar McMagyar 1 año hace
23.9 improvement.

No safety issues

Get the sick the drug

The fda process sucks
👍️0
govprs govprs 1 año hace
No they still have to complete another trial. It says so in the pr. If you missed the pump to 6ish then im sorry for you.
👍️0
McMagyar McMagyar 1 año hace
23.9 point improvement!
That is incredulous!

INCREDULOUS!
👍️0
McMagyar McMagyar 1 año hace
25 ? Haha..
NDA now
Use now..

👍️0
govprs govprs 1 año hace
Sure they will but no nda till q1 2025. Plus this is heavily shorted.

I could be wrong and if I am atleast I made a few bucks today gltu
👍️0
McMagyar McMagyar 1 año hace
Word is they will be filing nda and become the first choice for all mental suffering humans..
Cross prescriptions for dementia..etcal..
Buy back in at $30
👍️0
govprs govprs 1 año hace
Yep it was a big day with phase 3 success. Word is they will need to raise cash

I sold out with a profit and will look to get back in at some point
👍️0

Su Consulta Reciente

Delayed Upgrade Clock